Jun 2026 (Q2 FY26) — Aug 6, 2026
Omada Health Q2 FY26 — Record Performance and Leadership Transition
Read the full callOmada Health (OMDA) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Omada Health earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 87.8 | +43.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 4.0 | +11.1 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 5.3 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$18.67 +2.47% · +$0.45
Performance −23.9% 1Y
1Y: $24.52 on 14 Oct 2025 → $18.67. High $26.78 (28 Oct 2025), low $10.94 (11 Feb 2026).
- Previous close
- $18.22
- 52-week range
- $10.94 – $26.78
- One year
- −26.52%
Overview
- Symbol
- OMDA
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Omada Health earnings calls (OMDA)
Financials
What the filings say
Net profit, year on year: +200% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 46 | 48 | 55 | 61 | 68 | 76 | 78 | 88 |
| Operating profit | -9 | -7 | -8 | -4 | -3 | 3 | -5 | 4 |
| Operating margin | −18.7% | −14.8% | −15.3% | −7.1% | −3.7% | 4.3% | −6.1% | 4.0% |
| Other income | -1 | -1 | -1 | -1 | -1 | 2 | 2 | 2 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Profit before tax | -9 | -8 | -9 | -5 | -3 | 5 | -3 | 5 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net profit | -9 | -8 | -9 | -5 | -3 | 5 | -3 | 5 |
| EPS ($ per share) | -1.18 | — | -1.15 | -0.24 | -0.06 | — | -0.05 | 0.09 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Equity capital | — | 0 | 0 |
| Reserves | — | -444 | -457 |
| Total liabilities | — | 86 | 76 |
| Fixed assets | — | 6 | 8 |
| Total assets | — | 151 | 305 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Cash from operations | -50 | -34 | 18 |
| Cash from investing | -3 | -4 | -6 |
| Cash from financing | 0 | -1 | 133 |
| Net cash flow | -52 | -39 | 146 |
| Capital expenditure | -0 | -1 | -1 |
| Free cash flow | -50 | -35 | 17 |
Insider filings
156 filings between Dec 2, 2025 and Oct 5, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$11.97M
61 sales by 4 insiders
95% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 26
- Award — granted as compensation
- 45
- Option exercise — converted options into shares
- 20
- Tax withheld — shares kept back by the company to cover tax
Also filed: 3 other filings, 1 gift.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Duffy Sean P. | — | $7.60M | Oct 1, 2026 |
| Cook Steven L. | — | $3.47M | Sep 10, 2026 |
| Shao Wei-Li | — | $520.0K | Sep 10, 2026 |
| Gracey Craig | — | $371.2K | Sep 9, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | HILLEMAN JERYL L Director | Award | 1,214 | $0 |
| Oct 5, 2026 | FETTER TREVOR Director | Award | 751 | $0 |
| Oct 5, 2026 | Klapstein Julie D Director | Award | 549 | $0 |
| Oct 5, 2026 | ROOT JONATHAN D Director | Award | 694 | $0 |
| Oct 1, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 4,314 | $90.2K |
| Oct 1, 2026 | Duffy Sean P. Chief Executive Officer | Option exercise 10b5-1 plan | 4,314 | $35.7K |
| Oct 1, 2026 | Duffy Sean P. Chief Executive Officer | Option exercise 10b5-1 plan | 12,944 | $75.3K |
| Oct 1, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 12,944 | $266.8K |
| Sep 10, 2026 | Shao Wei-Li President | Sale 10b5-1 plan | 400 | $9.0K |
| Sep 10, 2026 | Cook Steven L. Chief Financial Officer | Sale 10b5-1 plan | 600 | $13.5K |
| Sep 10, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 1,400 | $31.6K |
| Sep 10, 2026 | Shao Wei-Li President | Sale 10b5-1 plan | 3,636 | $79.2K |
| Sep 10, 2026 | Cook Steven L. Chief Financial Officer | Sale 10b5-1 plan | 6,200 | $135.1K |
| Sep 10, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 13,560 | $295.6K |
| Sep 9, 2026 | Gracey Craig Chief Accounting Officer | Sale 10b5-1 plan | 644 | $14.0K |
| Sep 5, 2026 | Cook Steven L. Chief Financial Officer | Tax withheld | 2,010 | $45.8K |
| Sep 5, 2026 | Shao Wei-Li President | Tax withheld | 1,843 | $42.0K |
| Sep 5, 2026 | Duffy Sean P. Chief Executive Officer | Tax withheld | 4,422 | $100.7K |
| Sep 1, 2026 | Gracey Craig Chief Accounting Officer | Tax withheld | 385 | $8.8K |
| Sep 1, 2026 | Duffy Sean P. Chief Executive Officer | Option exercise 10b5-1 plan | 12,944 | $75.3K |
| Sep 1, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 4,933 | $114.1K |
| Sep 1, 2026 | Duffy Sean P. Chief Executive Officer | Tax withheld 10b5-1 plan | 9,885 | $225.8K |
| Sep 1, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 7,344 | $169.8K |
| Sep 1, 2026 | Duffy Sean P. Chief Executive Officer | Option exercise 10b5-1 plan | 4,314 | $35.7K |
| Sep 1, 2026 | Shao Wei-Li President | Tax withheld | 6,180 | $141.2K |
| Sep 1, 2026 | Duffy Sean P. Chief Executive Officer | Option exercise 10b5-1 plan | 4,314 | $39.6K |
| Sep 1, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 5,600 | $135.9K |
| Sep 1, 2026 | Cook Steven L. Chief Financial Officer | Tax withheld | 4,493 | $102.6K |
| Sep 1, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 3,695 | $89.7K |
| Aug 27, 2026 | Cook Steven L. Chief Financial Officer | Option exercise 10b5-1 plan | 1,108 | $9.2K |
| Aug 27, 2026 | Cook Steven L. Chief Financial Officer | Sale 10b5-1 plan | 1,108 | $27.7K |
| Aug 12, 2026 | Shao Wei-Li President | Sale 10b5-1 plan | 9,418 | $235.6K |
| Aug 11, 2026 | Cook Steven L. Chief Financial Officer | Sale 10b5-1 plan | 1,607 | $40.2K |
| Aug 11, 2026 | Cook Steven L. Chief Financial Officer | Option exercise 10b5-1 plan | 1,607 | $13.3K |
| Aug 10, 2026 | Cook Steven L. Chief Financial Officer | Sale 10b5-1 plan | 15,235 | $381.4K |
| Aug 10, 2026 | Gracey Craig Chief Accounting Officer | Sale 10b5-1 plan | 1,042 | $26.1K |
| Aug 10, 2026 | Cook Steven L. Chief Financial Officer | Option exercise 10b5-1 plan | 694 | $5.3K |
| Aug 10, 2026 | Cook Steven L. Chief Financial Officer | Option exercise 10b5-1 plan | 13,499 | $111.8K |
| Aug 10, 2026 | Gracey Craig Chief Accounting Officer | Option exercise 10b5-1 plan | 1,042 | $6.8K |
| Aug 10, 2026 | Cook Steven L. Chief Financial Officer | Option exercise 10b5-1 plan | 1,042 | $8.3K |
| Aug 10, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 12,942 | $321.1K |
| Aug 10, 2026 | Duffy Sean P. Chief Executive Officer | Option exercise 10b5-1 plan | 12,942 | $118.8K |
| Aug 7, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 4,314 | $98.4K |
| Aug 7, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 4,314 | $90.2K |
| Aug 7, 2026 | Duffy Sean P. Chief Executive Officer | Option exercise 10b5-1 plan | 5,545 | $45.9K |
| Aug 7, 2026 | Duffy Sean P. Chief Executive Officer | Option exercise 10b5-1 plan | 3,083 | $28.3K |
| Aug 3, 2026 | Duffy Sean P. Chief Executive Officer | Sale 10b5-1 plan | 12,944 | $264.0K |
| Aug 3, 2026 | Duffy Sean P. Chief Executive Officer | Option exercise 10b5-1 plan | 12,944 | $75.3K |
| Jul 15, 2026 | Cook Steven L. Chief Financial Officer | Sale 10b5-1 plan | 400 | $9.6K |
| Jul 15, 2026 | Cook Steven L. Chief Financial Officer | Option exercise 10b5-1 plan | 12,150 | $100.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Omada Health, Inc.
Free account. Everything above stays public.
Write why you follow Omada Health, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading